We investigated associations of pre-clinical coronary heart disease (CHD), adolescence and adulthood CHD risk factors, and epicardial fat volume (EFV), which is thought to influence CHD pathology.
Introduction
Epicardial fat is visceral fat that surrounds the heart and the coronary arteries. The concentration of inflammatory markers is increased in epicardial fat tissue compared with that of subcutaneous fat, and in patients with coronary heart disease (CHD) compared with those without. 1 -4 Epicardial fat has been suggested to influence CHD development due to its proximity to the coronary arteries and lack of a physical barrier between it and the coronary artery walls and myocardium. Indeed, previous studies have found increased epicardial fat to be associated with incident CHD events, 5 -7 presence and severity of CHD, 8 total atherosclerotic plaque burden, 9 coronary artery calcium, 10 -14 carotid intima-media thickness (cIMT) and traditional risk factor levels, 6, 12 and to be increased among obese patients and those with type 1 1 and 2 15 diabetes and metabolic syndrome (MetS). 16, 17 However, controversy still remains as to whether epicardial fat volume (EFV) is a truly independent fat deposit or a marker of overall adiposity. In a number of studies, associations between CHD risk factor levels and EFV have been lost after adjustment for measures of overall adiposity, such as body-mass index (BMI) or waist circumference. 8, 10, 12 We sought to examine the correlations between CHD risk factors and data from carotid ultrasound and coronary artery calcium (CAC) measurements with EFV quantified from multidetector computed tomography (CT) in a population-based sample of middle-aged adults who were first screened for clinical risk factors as adolescents.
To our knowledge, no previous studies have examined the association of adolescence risk factors on adult EFV.
Methods Participants
The Cardiovascular Risk in Young Finns Study is an ongoing follow-up of atherosclerosis risk factors of Finnish children and young adults carried out in all five Finnish university cities with medical schools (Helsinki, Kuopio, Oulu, Tampere, and Turku) and their rural surrounds. The first cross-sectional survey was conducted in 1980 on 3596 participants aged 3 -18 years. Follow-up surveys were conducted in 1983, 1986, 2001, and 2007 . In 2007, 2204 individuals of the original cohort participated. 18 In 2008, a cardiac CT study to measure CAC was conducted among 589 individuals, then aged 40 -46 years. This was a convenience sample; the CT study was offered to all of the 802 participants from the three oldest cohorts who resided in the three centres (Turku, Tampere, and Kuopio) with CAC imaging capability, with the attendance rate equalling 73%. EFV was quantified for 557 subjects with interpretable CT scans ( Figure 1 ). Participants gave written informed consent and the study was approved by local ethics committees.
Clinical characteristics
The BMI was calculated as weight, kg/(height, m) 2 . Blood pressure was measured using a standard mercury sphygmomanometer in 1980 and a random zero sphygmomanometer in 2007. Smoking habits, alcohol intake, and physical activity were inquired with a questionnaire. Smoking was defined as daily smoking in adolescence and/or in adulthood. Ever smoking was defined as a history of daily smoking at any time. Physical activity index was calculated as a metabolic equivalent index by assessing the duration, intensity, and frequency of physical activity, including leisure-time physical activity and commuting. 19 Subjects reported their weekly consumption of cans or bottles (1/3 L) of beer, glasses (12 cL) Figure 1 Flow chart of the study sample from 1980 to 2007. Analyses were repeated after excluding 70 participants with regular antihypertensive, lipid-lowering, or diabetes medication with similar results as seen in the final study population.
Association of CHD risk factors, CAC, and EFV of wine, and shots (4 cL) of strong alcohol. Alcohol intake per day was calculated from the total weekly volume of different beverages consumed. Information on food consumption was assessed with food frequency questionnaires.
Biochemical analyses
Venous blood samples were taken after an overnight fast. Standard methods were used to determine glucose, total cholesterol, high-density lipoprotein cholesterol (HDL-C), triglyceride, Apo-B, and Apo-A1 concentrations. Low-density lipoprotein cholesterol (LDL-C) was calculated indirectly using the Friedewald formula. 18 In 1980, serum insulin was measured using a modification of the immunoassay method and in 2007, by microparticle enzyme immunoassay kit. Serum high-sensitivity C-reactive protein (CRP) was analysed with a turbidimetric immunoassay kit. HOMA-index was calculated as (insulin × fasting glucose)/22.5.
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Subjects were considered to have type 2 diabetes if they: (i) had a fasting glucose ≥7.0 mmol/L (≥125 mg/dL), (ii) reported receiving oral hypoglycaemic agents and/or insulin and did not have type 1 diabetes, or (iii) reported a history of physician-diagnosed DM2. 21 To identify subjects with MetS, we used the modification of the original National Cholesterol Education Programme definition by a joint expert group of the National Heart, Lung, and Blood Institute and the American Heart Association.
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Computed tomography imaging
The CT scans were performed with a GE Discovery VCT 64-slice CT/ PET device (Turku), a Philips Brilliance 64-slice CT device (Tampere), and a Siemens Somaton Sensation 16-slice CT device (Kuopio). The average radiation dose received by the subjects was 1.43 mSv. CAC scores were calculated using the Agatston method. 23 The coefficient of variation for intraobserver measurements was 4.0%. A phantom with deposits of known calcium concentration was scanned twice using three projections at the three study centres; the coefficient of variation between the phantom scans was 3.9%. Presence of CAC was defined as an Agatston score of 1 or greater. Full details of the study protocol have been published previously. 24 Total thoracic fat, extra-pericardial fat and EFVs (TTFV, EPFV and EFV, respectively) in cubic centimetre were calculated using a GE Advantage Workstation (version 4.4) as described by Mahabadi et al. 7 Fat volumes were assessed semi-automatically by first manually tracing regions of interest on non-consecutive slices and making necessary adjustments on the computed interpolations. The analyser then traced the pericardial sac on the images. Within the region of interest, fat was defined as voxels within a window of 2195 to 245 Hounsfield units. Total thoracic fat was defined as any fat tissue located within the thorax from the level of the right pulmonary artery to the diaphragm and from the chest wall to the descending aorta as well as any fat tissue inside the pericardial sac. EFV was defined as fat tissue within the pericardial sac. EPFV was defined as the difference between TTFV and EFV. One reader blinded to participant details performed all measurements. In total, 32 subjects' scans were non-interpretable due to missing data. Of the three fat volumes, EFV was chosen as the primary outcome because of its reported associations with CHD development.
Ultrasound imaging
Ultrasound studies were performed by trained physicians and sonographers following standardized protocols in five centres. Mean IMT was derived using a minimum of four measurements at end diastole from the posterior (far) wall of the left carotid artery approximately 10 mm proximal to the carotid bifurcation. Measurements were made by one experienced reader (M.J.) who was blinded to the subjects' clinical
characteristics. An ultrasound imaging device with a high-resolution system (Sequoia 512; Acuson, CA, USA) and 13.0 MHz linear-array transducer was used. The coefficient of variation between visits was 6.4%. To assess carotid distensibility, the best-quality cardiac cycle was selected from a continuous 5-s image file. The common carotid diameter was measured at least twice during end diastole. Ultrasound and concomitant brachial blood pressure measurements were used to calculate Cdist: Cdist ¼ [(Ds 2 Dd)/Dd]/(Ps 2 Pd), where Dd is diastolic diameter, Ds systolic diameter, Ps systolic blood pressure, and Pd diastolic blood pressure.
To assess brachial flow-mediated dilatation, the left brachial artery diameter was measured at rest and during reactive hyperaemia. Increased flow was induced by inflation of a pneumatic tourniquet placed around the forearm to a pressure of 250 mmHg for 4.5 min followed by release. The average of three measurements at rest and 40, 60, and 80 s after cuff release was used to derive maximum flow-mediated dilatation. The maximal vessel diameter in scans after reactive hyperaemia was expressed as the percentage relative to resting scan. Full details of the methods have been described previously.
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Statistical analysis
The EFV, EPFV, and TTFV were not normally distributed, therefore, a log-transformation was used. Additionally, subjects were divided into sex-specific quartiles based on their EFVs. Associations between fat volumes and risk factors were assessed using multivariable analysis of variance models adjusted for age and sex. A multivariable regression model including sex, age, BMI, Apo-B, and ever smoking was finally created to establish the magnitude of the individual risk factors' effect on EFV. Age and sex interactions were examined and they were nonsignificant. Using multi-level mixed modelling with maximum-likelihood estimation, we compared the BMI trajectory (from years 1980, 1983, 1986, 2001 , and 2007) as a function of age for two groups; those with EFV in the lowest quarter in 2007 vs. those with EFV in the highest quarter in 2007. This approach allows for missing data (assuming missing data are random) and takes into account correlations between repeated measures on the same individual. We fitted interaction terms between EFV group (lowest vs. upper quarter) and time to compare the trajectory of BMI between EFV groups, allowing us to determine the age at which differences in BMI were apparent. An unstructured covariance matrix was used in all models. A P-value of ,0.05 was considered statistically significant. All computations were performed using SAS version 9.3 or STATA version 13.1.
Results
Risk factor levels among those who participated and those who did not are shown in Supplementary data online, Table S1 . Seventy participants were either on antihypertensive (n ¼ 62), lipid-lowering medication (n ¼ 19), oral medication for diabetes (n ¼ 2), or used injected insulin (n ¼ 4). No substantial difference in results was observed after these participants were excluded from the analyses (data not shown).
Mean EFV was 79. Association of CHD risk factors, CAC, and EFV CRP, systolic and diastolic blood pressure, insulin, and fasting glucose as well former smoking, alcoholic intake, HOMA-index, MetS prevalence, and cIMT increased, while HDL-C levels, physical activity index, and carotid distensibility decreased across EFV quartiles. Adolescent skinfold thickness, BMI, and insulin levels were higher with increasing EFV (Table 2) . However, only sex, adult waist circumference, BMI, Apo-B, former smoking, MetS prevalence, and alcohol intake remained statistically significant after multivariable adjustment. Prevalence of CAC was not different across quartiles. In addition, the severity of CAC as quantified by the Agatston score was not associated with EFV (data not shown).
In a multivariable regression model including sex, age, waist circumference, Apo-B and a history of smoking, all risk factors except age showed a positive correlation with EFV ( Table 3 ). Figure 2 shows the trajectories for BMI for the highest and lowest quarters of EFV and Supplementary data online, Table S2 shows the raw BMI values for all EFV quarters. These data show that those in the lowest vs. the highest quarter of EFV at the 2007 follow-up had consistently lower BMI across the early life-course. Participants in the highest quarter of EFV in 2007 had, on average, greater mean levels of BMI (2.2 kg/m 2 , 95%CI, 1.5 -2.9, P , 0.001) across the lifecourse. The gap between groups increased as participants aged, particularly after adolescence ( Figure 2 ). For example, at age 12 the gap between the two groups was 1.8 kg/m 2 and at age 45, it was 9.0 kg/m 2 .
Discussion
Some previous studies have suggested that increased EFV may play a role in the development of CHD. Therefore, we examined the associations between CHD risk markers and EFV in population of young and middle-aged adults. We found that CHD risk markers were less favourable with increasing EFV but the associations were attenuated in multivariable adjustment. Therefore, we found no evidence that increased EFV would be independently associated with markers of pre-clinical atherosclerosis, including increased CAC prevalence, in our population. EFV was most strongly associated with BMI and waist circumference. Subjects with higher EFV had higher BMI from age 12 and this association became more pronounced later in life suggesting that life-long exposure to higher BMI plays a role in the development of EFV. Previously, a number of studies have established independent associations between risk factors including waist circumference, male sex, LDL-C and HDL-C levels, diabetes and impaired fasting glucose, MetS and current as well as former smoking, and EFV. 6,8,12,15 -17,26 In many cases, however, the associations have been attenuated or even lost their statistical significance after adjustment for adiposity measures, such as BMI, waist circumference or visceral adipose tissue volume. 8, 10, 12 Similarly in our study, risk factor levels were less favourable across increasing EFV quartiles but for most risk factors, the differences were not statistically significant after adjustment for BMI. This is in agreement with a recent study, where associations with EFV were not statistically significant after adjustment for visceral abdominal adipose tissue in non-obese patients. 27 This may indicate that the association of epicardial fat and risk factors is at least partly explained by a strong association between other adiposity measures and EFV. In addition, prevalence of MetS increased across EFV quartiles, which could be expected given the strong association of adiposity measures with EFV in our study. This finding is in agreement with previous studies. 16, 17, 28 To our knowledge, no other follow-up study has been conducted over adolescence risk factors or life-long exposure to risk factors and EFV in adulthood. We and others have, however, shown that adverse childhood or adolescence risk factor levels are predictive of CAC 24, 29 and carotid atherosclerosis 25, 30 in adulthood. Schusterova et al.
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found epicardial adipose tissue thickness measured by echocardiography in overweight children to be associated with blood pressure, triglycerides, uric acid, HDL-C, apo-B, and alanine aminotransferase but it was not a stronger indicator of cardiometabolic risk than BMI alone. In our study, a significant difference in BMI was observed already at age 12 years between those with low vs. high EFV in adulthood. This difference became more pronounced later in life, especially after adolescence, and continued into mid-adulthood. Ferreira et al.
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used a similar life-course analysis approach regarding carotid stiffness and found that those with stiffer carotid arteries at age 36 years had greater levels of blood pressure and central fatness. These findings add to the evidence base that life-long exposure to risk factors is an important factor for the development of CHD-related changes. According to our results, however, other adolescence risk factors than BMI do not seem to play a role in the development of EFV. This is in contrast to our previous findings from the same study population concerning CAC 24 and carotid atherosclerosis. 25 Unlike several previous studies, 9,12 -14 we could not demonstrate an association between EFV and CAC prevalence or severity after adjustment for sex, age, and waist circumference. Our study confirms the finding by Bucci et al. 33 in subjects with a moderate pretest likelihood of CAD; the correlations between EFV and EPFV and CAC disappeared when correcting for age and sex. Similar results were found by Mahabadi et al. 6 in the Heinz Nixdorf Recall Study, in which they concluded that shared risk factors ultimately accounted for the linkage of epicardial fat and CAC, and Pracon et al. 34 who found that epicardial adipose tissue radiodensity, but not volume, was associated with CAC. In addition, Alexopoulos et al. 11 found that EFV was greater in patients with mixed or non-calcified plaques compared with those with calcified plaques and Gorter et al. 35 found that in patients with suspected CHD, EFV was not associated with CAC overall but in those with low BMI, an association was found. A recent meta-analysis found no difference in EFV between groups of increasing CAC scores. 36 A large proportion of studies showing an association between EFV and CAC included selected populations with either known or suspected CHD and were therefore possibly biased. In the Framingham Study, subjects were considerably older and had more prevalent CAC than in our study. 12 It is possible that epicardial fat influences CHD development through shared risk factors with CAC. We additionally found that higher cIMT and decreased carotid distensibility were associated with EFV when adjusted for age and sex, however, in multivariable models these associations did not prevail. A few studies have addressed the possible associations between EFV and carotid artery ultrasound measurements. Sengul et al. 18 found that EFV measured by ultrasound was associated with increased IMT in patients with MetS. In the MultiEthnic Study of Atherosclerosis, carotid stiffness, 37 but not IMT, 38 was associated with EFV even after adjustment for BMI and waist circumference and CHD risk factors. We were also able to link EFV measurements with brachial artery endothelial-dependent flowmediated vasodilation capacity, and found no association. Therefore, we found no evidence that increased EFV would play an independent role in the development of early structural and functional changes of atherosclerosis. For this reason, we find it unlikely that measurement of EFV in clinical practice would bring additional information of CHD risk over and above that gained from CAC measurement alone. A strength of this study is that the study population is a nonselected population thus representative of the general population. Owing to the longitudinal design of this study, bias due to differential loss to follow-up is a potential concern. However, we have previously shown those lost to follow-up do not differ with respect to the major risk factors at baseline 18 and attrition in our study has been substantially less when compared with other similar studies. 39 Moreover, we found no significant differences between the subset that participated at clinics in 2007 but did not attend cardiac CT scans and those that attended both. Collectively therefore, we expect bias due to Figure 2 Comparison of the BMI life-course trajectory between participants in the lowest (white circles) vs. the highest (black boxes) sex-specific quarter of EFV in adulthood. *P , 0.001.
Association of CHD risk factors, CAC, and EFV differential loss to follow-up to be minimal. Visceral or subcutaneous adipose tissue was not measured because the field of view in the CT scans only covered the heart with varying marginal superiorly and inferiorly and so relations with EFV and these measures could not be studied. Rather, an indirect marker for abdominal adipose tissue, waist circumference, was used. Another limitation is that the IMT and FMD measurements were performed operator-dependently instead of utilizing an automated or semi-automated operatorindependent system. Finally, we are unable to conclude concerning the direction of effect between BMI and EFV. For example, our lifecourse models posit that the BMI separation among the extremes of EFV was already apparent at age 12 years. Because we did not have EFV data from across the life-course we are unable to discount that EFV separation occurred before, after, or at the same time as BMI.
In conclusion, most risk associations between risk factor levels and EFV were attenuated in multivariable analyses. Sex, BMI, and waist circumference measured in adulthood were most strongly associated with EFV; Apo-B, a history of smoking, and alcohol intake showed a weaker association with EFV. BMI in adolescence and throughout young adulthood was higher across increasing EFV. No evidence was found that increased EFV would be independently associated with increased CAC prevalence or other structural and functional markers of pre-clinical atherosclerosis.
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